High levels of hemoglobin promote carotid adventitial vasa vasorum neoangiogenesis in chronic kidney disease

Autor/a

Arcidiacono, Maria V.

Martínez Alonso, Montserrat

Belart, Montserrat

Vilar, Ana

Martín, Marisa

Craver Hospital, Lourdes

Betriu i Bars, M. Àngels

Mauricio Puente, Dídac

Valdivielso Revilla, José Manuel

Fernández i Giráldez, Elvira

Borràs, Mercè

Data de publicació

2017-06-16T07:50:18Z

2017-06-16T07:50:18Z

2017-01-04

2017-06-16T07:50:18Z



Resum

Chronic kidney disease (CKD) patients, characterized by traditional and nontraditional risk factors, are prone to develop atheromatosis and thus cardiovascular events and mortality. The angiogenesis of the adventitial vasa vasorum (aVV) surrounding the carotid has been described as the atheromatosis initiator. Therefore, the aim of the study was to (1) evaluate if the carotid aVV in CKD patients increases in comparison to its physiological value of healthy patients; (2) explore which traditional or nontraditional risk factor including inflammation, bone and mineral metabolism, and anemia could be related to the aVV angiogenesis. CKD patients without previous cardiovascular events (44, stages 3-4; 37, stage 5D) and 65 healthy subjects were compared. The carotid aVV and the intima-media thickness (cIMT) were evaluated by ultrasound. CKD patients at stages 3-4 showed higher aVV of the right carotid artery even after adjusting for age. Importantly, a multiple linear regression model showed hemoglobin levels > 12.5 g/dL as the factor for an estimated higher aVV of the right carotid artery. In conclusion, the association of hemoglobin with higher aVV could suggest the role of high hemoglobin in the higher incidence of adverse cardiovascular outcomes in CKD patients.


This study was funded by the Health Institute Carlos III, Ministry of Economy and Competitiveness, Spain, Grants no. PI09/1999.

Tipus de document

Article
Versió publicada

Llengua

Anglès

Matèries i paraules clau

Insuficiència renal crònica; Hemoglobina; Angiogènesi; Chronic renal failure; Hemoglobin; Neovascularization

Publicat per

Hindawi

Documents relacionats

Reproducció del document publicat a: https://doi.org/10.1155/2017/3795142

Mediators of Inflammation, 2017, vol. 2017, p. 1-11

Drets

cc-by (c) Arcidiacono, Maria V. et al., 2017

http://creativecommons.org/licenses/by/3.0/es

Aquest element apareix en la col·lecció o col·leccions següent(s)